{{Rsnum
|rsid=4648127
|Gene=NFKB1
|Chromosome=4
|position=102614748
|Orientation=plus
|GMAF=0.04224
|Gene_s=NFKB1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 76.9 | 23.1 | 0.0
| HCB | 86.7 | 13.3 | 0.0
| JPT | 86.7 | 13.3 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 86.7 | 13.3 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}[http://www.ivanhoe.com/channels/p_channelstory.cfm?storyid=30109 news] linked to a 21% reduced risk of [[lung cancer]]
{{PMID Auto
|PMID=23044494
|Title=Genetic variation in innate immunity and inflammation pathways associated with lung cancer risk
|OA=1
}}

{{on chip | FTDNA}}